Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 474,360 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Daiichi Sankyo Company Ltd (PK) | DSNKY | OTCMarkets | Depository Receipt |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.34 | 4.34% | 32.20 | 06:59:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 31.96 | 31.84 | 32.27 | 32.20 | 30.86 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 620 | 474,360 | 32.1185 | 15,235,739 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 05:59:59 | 86 | 32.27 | USD |
News Daiichi Sankyo (PK)
| Date | Time | Source | Heading |
|---|---|---|---|
| 23/10/2023 | 17:49 | Dow Jones News | AstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU.. |
| 20/10/2023 | 11:30 | Dow Jones News | Merck, Daiichi Sankyo Ink Commercialization Deal for Up to.. |
| 22/9/2023 | 16:53 | Dow Jones News | AstraZeneca Says Trial Results For Breast Cancer Drug Were.. |
| 16/9/2023 | 00:51 | Dow Jones News | AstraZeneca's Lung-Cancer Treatment Gets Recommended for.. |
| 11/9/2023 | 16:55 | Dow Jones News | AstraZeneca Says Datopotamab Deruxtecan Combined With.. |
| 03/7/2023 | 16:50 | Dow Jones News | AstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows.. |
| 05/6/2023 | 22:53 | Dow Jones News | AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful,.. |
DSNKY Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
